Enhanced activity of hiv vaccine using a second generation...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 31/7088 (2006.01) A61K 39/21 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2557443

The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS.

L'invention concerne l'utilisation thérapeutique d'un oligonucléotide immunomodulateur de seconde génération, en combinaison avec un antigène ou un immunogène VIH-1 pour renforcer la capacité à réduire le risque d'infection par VIH et pour réguler la progression de l'infection à VIH, de manière à prévenir le syndrome apparenté au SIDA, ainsi que le SIDA.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enhanced activity of hiv vaccine using a second generation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhanced activity of hiv vaccine using a second generation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced activity of hiv vaccine using a second generation... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1371152

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.